Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,464 | 4,568 | 4,649 | 4,769 | 116 |
| Marketable Securities | N/A | N/A | N/A | N/A | 24 |
| Receivables | 34 | 14 | 57 | 51 | 46 |
| TOTAL | $4,561 | $4,587 | $4,738 | $4,866 | $249 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 0 | 0 | 1 |
| Other Non-Current Assets | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $4 | $4 | $3 | $3 | $3 |
| Total Assets | $4,564 | $4,591 | $4,740 | $4,869 | $252 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50 | 47 | 103 | 69 | 54 |
| Accrued Expenses | 53 | N/A | 8 | 30 | 95 |
| TOTAL | $136 | $47 | $110 | $99 | $649 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $136 | $47 | $110 | $99 | $649 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 166 | 166 | 166 | N/A | 180 |
| Common Shares | 33 | 33 | 33 | 33 | 36 |
| Retained earnings | 2,594 | 2,710 | 2,796 | 2,936 | -2,448 |
| TOTAL | $4,428 | $4,544 | $4,630 | $4,770 | $-397 |
| Total Liabilities And Equity | $4,564 | $4,591 | $4,740 | $4,869 | $252 |